Add-on Study for Protocol G200802 (NCT02463032): Effect of GTx-024 on Maximal Neuromuscular Function and Lean Body Mass
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: ER+ and AR+ Breast Cancer
Interventions: DRUG: GTx-024 9 or 18 mg
Sponsor: GTx